Biological properties of VEGF/VPF receptors

Cancer and Metastasis Reviews

Volumn 15, Issue 2, 1996, Pages 159-163

  Terman, Bruce I ^a   Dougher Vermazen, Maureen ^a  

^a PFIZER INC   (United States)

Author keywords

Angiogenesis; Receptors; VEGF

Indexed keywords

HEPARIN; PROTEOGLYCAN; VASCULOTROPIN;

ANGIOGENESIS; DNA LIBRARY; GENE EXPRESSION REGULATION; LIGAND BINDING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030055208     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00437468     Document Type: Review

References (42)

1. Gospodarowicz D, Abraham FA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 86: 7311-7315, 1989
2. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992
3. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk1 mutant. Nature 367: 576-579, 1994
4. Kim J, Li B, Winer J, Armaninum M, Gillet N, Phiips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 262: 841-844, 1993
5. Terman BI, Carrion ME, Kovacs E, Rasmussen R, Eddy RL, Shows TB: Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6: 1677-1683, 1991
6. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Com 187: 1579-1586, 1992
7. Mattews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 88: 9026-9030, 1991
8. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846, 1993
9. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5: 519-524, 1990
10. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992
11. Fantl WJ, Johnson DE, Williams LT: Signalling by receptor tyrosine kinases. Ann Rev Biochem 62: 453-481, 1993
12. Pajusola K, Aprlikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K: FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52: 5738-5743, 1992
13. Galland F, Karamysheva A, Pebusque M-J, Borg J-P, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D: The FL4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor. Oncogene 8: 1233-1240, 1993
14. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312, 1989
15. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989
16. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA, Thomas KA: Amino acid and cDNA sequence of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87: 2628-2632, 1990
17. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88: 9267-9271, 1991
18. Kendall RL, Wang G, DiSalvo J, Thomas KA: Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem Biophys Res Commun 201: 326-330, 1994
19. Park JE, Chen HH, Winer J, Houck KA, Farrara N: Placenta growth factor. J Biol Chem 269: 25646-25654, 1994
20. Terman BI, Khandke L, Dougher-Vermazon M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P, Eisinger M: VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11: 187-195, 1994
21. DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA: Purification and characterization of a naturally occurring vascular growth factor/placenta growth factor heterodimer. J Biol Chem 270: 7717-7723, 1995
22. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld: The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267: 6093-6098, 1992
23. 165 with soluble and cell associated flk-1 receptors. J Biol Chem 269: 12456-12461, 1994
24. Kaplan J, Dougher-Vermazen M, Terman BI: Manuscript in preparation
25. Ornitz D, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P: Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 12: 240-247, 1992
26. Kan M, Wang F, Xu F, Crabb JW, Hou J, Mckeehan WL: An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259: 1918-1921, 1993
27. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 58: 575-606, 1989
28. 165 to its receptors. Biochem Biophys Res Commun 203: 1339-1347, 1994
29. 121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270: 11322-11326, 1995
30. Klagsbrun M, Baird A: A dual receptor system is required for basic fibroblast growth factor activity. Cell 67: 229-231, 1991
31. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. J Biol Chem 266: 11947-11954, 1991
32. Houck KA, Farrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5: 1806-1814, 1991
33. Waltenberger J, Claesson-Welsh L, Siegnahn A, Shibuya S, Heldin C-H: Different signal transduction properties of KDR and Fltl. two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988-26995, 1994
34. Dougher-Vermazen M, Holmes J, Bohlen P, Terman BI: Biological activity of autophosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF receptor. Biochem Biophys Res Commun 205: 728-738, 1994
35. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M: A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10: 135-147, 1995
36. Cunningham SA, Waxham MN, Arrate PM, Brock TA: Interaction of the FLT-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 270: 20254-20257, 1995
37. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995
38. Wizigmann-Voos S, Breier G, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55: 1358-1364, 1995
39. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848, 1992
40. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N: Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1797, 1995
41. Peters KG, De Vries C, Williams LT: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90: 8915-8919, 1993
42. Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van De Water L: Overexpression of vascular permeability factor (VPF/ VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunology 22: 2801-2807, 1995